GO:0070182 DNA polymerase binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070182 DNA polymerase binding is a molecular function defined as binding to a DNA polymerase, enabling proteins to physically associate with DNA-synthesizing enzymes [1, 2].
• DNA polymerase binding is essential for processivity, replication fidelity, and coordination of leading- and lagging-strand synthesis [3, 4, 6].
• Key proteins that bind DNA polymerases include PCNA, REV1, helicases, and single-stranded DNA-binding proteins, which tether polymerases to DNA and regulate their activity [6, 8].
• Dysregulation of DNA polymerase binding is linked to cancer, chemoresistance, and mitochondrial disorders [5, 8].
• CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the functional consequences of DNA polymerase binding [4, 8].
• EDITGENE provides comprehensive CRISPR services to study DNA polymerase binding in health and disease.
Description
DNA polymerase binding (GO:0070182) is a molecular function that describes the physical interaction between a protein and a DNA polymerase enzyme [1, 2]. This binding event is fundamental to genome maintenance, as it regulates the recruitment, processivity, and coordination of DNA synthesis during replication and repair [3, 4]. Proteins that bind DNA polymerases often act as scaffolds, processivity factors, or regulatory subunits, ensuring that DNA synthesis is tightly controlled in space and time [6, 8]. Understanding DNA polymerase binding is therefore critical for deciphering mechanisms of replication, DNA damage tolerance, and mutagenesis [5, 7]. Research into DNA polymerase binding has been accelerated by structural biology, single-molecule biophysics, and CRISPR-based functional genomics [4, 8]. For example, the interaction between the translesion DNA polymerase REV1 and PCNA is mediated by a specific PCNA-binding motif, and disrupting this interaction affects mutagenesis and cell survival after DNA damage. Similarly, helicase-polymerase coupling in bacteriophage and human systems highlights the dynamic nature of these interactions [4, 6]. This article provides a comprehensive overview of GO:0070182, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and state-of-the-art research methods, including CRISPR-based models. All facts are supported by peer-reviewed literature to ensure accuracy and reproducibility.
DNA polymerase binding At A Glance
| GO ID | GO:0070182 |
|---|---|
| GO term | DNA polymerase binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to a DNA polymerase enzyme, often regulating its activity, processivity, or localization [1, 2]. |
| Related processes | DNA replication, DNA repair, translesion synthesis, and cell cycle checkpoint control [4, 6, 8]. |
| Key interacting proteins | PCNA, REV1, helicases, single-stranded DNA-binding proteins, and polymerase accessory subunits [6, 8]. |
| Experimental evidence | Demonstrated by in vitro binding assays, structural studies, and genetic interactions [3, 7, 8]. |
What Is GO:0070182?
DNA polymerase binding (GO:0070182) is defined by the Gene Ontology as the binding to a DNA polymerase. In other words, it is the molecular function of selectively interacting with any enzyme that catalyzes the synthesis of DNA from deoxyribonucleoside triphosphates, typically using a DNA template [1, 2]. This function is distinct from DNA polymerase activity itself; it describes the binding event that anchors, regulates, or modulates the polymerase [3, 4].
Why Is DNA polymerase binding Important in Cell Biology?
DNA polymerase binding is crucial for maintaining genomic integrity because it ensures that DNA polymerases are correctly positioned and regulated during replication and repair [3, 4]. Proteins that bind DNA polymerases can enhance processivity, coordinate leading- and lagging-strand synthesis, and facilitate lesion bypass [6, 8]. Dysregulation of these interactions can lead to mutations, genomic instability, and diseases such as cancer [5, 8].
• Regulates DNA replication fidelity and speed by tethering polymerases to DNA [3, 4].
• Coordinates leading- and lagging-strand synthesis through helicase-polymerase coupling.
• Enables translesion synthesis by recruiting specialized polymerases to sites of DNA damage.
• Plays a role in cell cycle progression and checkpoint control.
• Influences sensitivity to chemotherapeutic agents that target DNA replication [5, 8].
• Associated with mitochondrial DNA maintenance and related disorders.
• Provides targets for antiviral and anticancer drug development [5, 8].
• Essential for genome editing outcomes, as CRISPR-based knock-in relies on DNA polymerase activity.
• Key to understanding mutagenesis and evolution.
• Offers opportunities for synthetic biology and biotechnology applications.
Molecular Mechanism of DNA polymerase binding
Recognition and Initial Binding
In simple terms: The binding protein finds and attaches to the DNA polymerase.
The initial step in DNA polymerase binding involves specific molecular recognition between the binding protein and the DNA polymerase. This can occur through conserved motifs, such as the PCNA-binding motif (PIP box) found in many polymerase-interacting proteins. Structural studies have revealed that binding often involves electrostatic interactions and shape complementarity, as seen in the interaction between REV1 and PCNA. In vitro binding assays, such as electrophoretic mobility shift assays and isothermal titration calorimetry, have been used to quantify these interactions [3, 7].
Conformational Changes and Complex Assembly
In simple terms: Binding causes shape changes that allow the polymerase to work better.
Upon binding, both the DNA polymerase and its partner protein may undergo conformational changes that enhance catalytic activity or processivity. For example, the worm-like movement model for DNA polymerase translocation suggests that binding to DNA and accessory proteins induces dynamic changes that move the DNA within the binding cleft. In the context of helicase-polymerase coupling, the binding of a helicase to a polymerase can coordinate their activities to unwind and synthesize DNA simultaneously. These conformational changes are often studied using X-ray crystallography, cryo-electron microscopy, and molecular dynamics simulations.
Functional Consequences: Processivity and Regulation
In simple terms: The binding makes the polymerase more efficient and controlled.
DNA polymerase binding often increases the processivity of the polymerase, allowing it to synthesize long stretches of DNA without dissociating. This is exemplified by the sliding clamp PCNA, which tethers the polymerase to DNA. Binding can also serve regulatory roles, such as targeting polymerases to specific DNA lesions for translesion synthesis. Thermodynamic profiling has been used to dissect the contributions of template binding, substrate incorporation, and exonuclease function in polymerase complexes. Additionally, binding can be modulated by post-translational modifications, though specific examples are beyond the scope of this article.
Dynamics and Turnover
In simple terms: The binding is not permanent; proteins come and go.
DNA polymerase binding is dynamic, with association and dissociation rates that can be regulated by cellular signals or DNA damage. Single-molecule studies have revealed that polymerases can slide along DNA and exchange binding partners. The interaction between REV1 and PCNA, for instance, is transient and regulated during the cell cycle. Understanding these dynamics is essential for comprehending how cells balance efficient DNA synthesis with the need to respond to DNA damage [4, 6].
Key Genes Involved in GO:0070182 DNA polymerase binding
The following genes encode proteins that bind DNA polymerases and are critical for DNA replication, repair, and damage tolerance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCNA | Sliding clamp that tethers DNA polymerases to DNA | Central to processivity; target for cancer therapy |
| REV1 | Translesion DNA polymerase that binds PCNA via PIP motif | Mutagenesis and chemoresistance |
| POLA1 | Catalytic subunit of DNA polymerase alpha | Initiation of DNA replication |
| POLB | DNA polymerase beta involved in base excision repair | Base excision repair and chemotherapy response |
| POLD1 | Catalytic subunit of DNA polymerase delta | Leading and lagging strand synthesis |
| POLE | Catalytic subunit of DNA polymerase epsilon | Leading strand synthesis and proofreading |
| POLH | DNA polymerase eta involved in translesion synthesis | UV damage tolerance and xeroderma pigmentosum |
| POLI | DNA polymerase iota involved in translesion synthesis | Lesion bypass and mutagenesis |
| POLK | DNA polymerase kappa involved in translesion synthesis | Bulky adduct bypass |
| POLQ | DNA polymerase theta involved in microhomology-mediated end joining | Alternative end joining and genome stability |
| MCM2-7 | Helicase complex that interacts with polymerases | Replication fork progression |
| RPA | Single-stranded DNA-binding protein that interacts with polymerases | Replication and repair coordination |
| RFC | Clamp loader that loads PCNA onto DNA | PCNA loading and polymerase switching |
| TOP1 | Topoisomerase that interacts with polymerases | Replication and transcription |
| FEN1 | Flap endonuclease that binds PCNA and polymerases | Okazaki fragment maturation |
| LIG1 | DNA ligase I that interacts with replication proteins | Ligation of Okazaki fragments |
| T4 gp43 | Bacteriophage T4 DNA polymerase | Model for polymerase binding studies |
How Is DNA polymerase binding Regulated?
DNA polymerase binding is regulated at multiple levels. Post-translational modifications, such as ubiquitination and phosphorylation, can alter the affinity of binding partners for polymerases. For example, monoubiquitination of PCNA is required for recruiting translesion polymerases like REV1 to sites of DNA damage. Additionally, the cell cycle regulates the expression and localization of many polymerase-binding proteins, ensuring that DNA synthesis occurs only during S phase. Thermodynamic and kinetic parameters of binding can be modulated by the local environment, including ionic strength and the presence of specific DNA structures. While pathways like mTOR and the integrated stress response are not directly implicated in DNA polymerase binding per se, they can influence overall DNA replication capacity by regulating protein synthesis and degradation.
DNA polymerase binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| REV1 | Chemoresistance in cancer | Knockout in cancer cell lines followed by drug sensitivity assays |
| PCNA | Cancer progression and DNA damage response | Point mutations in PCNA to disrupt binding |
| POLH | Xeroderma pigmentosum variant | Knockout in fibroblasts and UV sensitivity tests |
| POLE | Hypermutated colorectal cancer | Knock-in of cancer-associated mutations |
| POLG | Mitochondrial disorders | Knockout in induced pluripotent stem cells |
Cancer and Chemoresistance
Alterations in DNA polymerase binding can contribute to cancer development and resistance to chemotherapy. For instance, overexpression of REV1, which binds PCNA, is associated with increased mutagenesis and resistance to platinum-based drugs. Similarly, mutations in POLE and POLD1 that affect polymerase interactions can lead to hypermutated cancers. Targeting these interactions is a promising therapeutic strategy.
Neurodegeneration and Mitochondrial Disorders
Defects in DNA polymerase binding can impair mitochondrial DNA replication, leading to mitochondrial disorders. For example, mutations in POLG, which encodes the mitochondrial DNA polymerase, or in its binding partners, can cause progressive external ophthalmoplegia and Alpers syndrome. Although POLG is not listed in the key genes table, the principle that polymerase binding is critical for mitochondrial function is well established.
Xeroderma Pigmentosum and UV Sensitivity
Deficiencies in translesion polymerases such as POLH (polymerase eta) that bind PCNA and other factors lead to xeroderma pigmentosum variant, characterized by extreme sensitivity to UV radiation and increased skin cancer risk.
From DNA polymerase binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of REV1-PCNA binding affect mutagenesis? | Knockout of REV1 or PCNA point mutant |
| What is the role of POLH in UV tolerance? | POLH knockout cells |
| How does POLE proofreading deficiency drive cancer? | POLE point mutation knock-in mice |
| Can we visualize polymerase binding in live cells? | Tagged knock-in of POLA1 with fluorescent protein |
| Does overexpression of PCNA increase processivity? | PCNA overexpression cell lines |
| What is the impact of POLQ binding on end joining? | POLQ knockout and knock-in |
How to Study the DNA polymerase binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EMSA | Binding affinity and specificity | Quantify DNA polymerase binding in vitro |
| ITC | Thermodynamics of binding | Measure Kd and stoichiometry |
| Cryo-EM | 3D structure of complexes | Visualize binding interfaces |
| Single-molecule FRET | Dynamic binding and conformational changes | Study polymerase translocation |
| CRISPR knockout | Loss-of-function phenotypes | Test gene essentiality |
| CRISPR knock-in | Tagged or mutant protein expression | Live-cell imaging |
| Thermodynamic profiling | Template binding and exonuclease activity | Characterize polymerase function |
In Vitro Binding Assays
In vitro binding assays such as electrophoretic mobility shift assays (EMSA), isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR) are used to measure the affinity and kinetics of DNA polymerase binding [3, 7]. These methods provide quantitative parameters like dissociation constants (Kd) and can reveal the effects of mutations on binding.
Structural Biology
X-ray crystallography and cryo-electron microscopy (cryo-EM) have been instrumental in visualizing the atomic details of DNA polymerase binding. For example, the structure of REV1 in complex with PCNA revealed the molecular basis of their interaction. These techniques help identify binding interfaces and conformational changes.
Single-Molecule Biophysics
Single-molecule techniques such as optical tweezers and fluorescence resonance energy transfer (FRET) allow real-time observation of DNA polymerase binding and movement. The worm-like movement model for polymerase translocation was proposed based on such studies. These methods provide insights into dynamic binding and processivity.
CRISPR-Based Functional Genomics
CRISPR knockout, knock-in, and point mutation models enable functional dissection of DNA polymerase binding in cells. For instance, knocking out REV1 or mutating its PCNA-binding motif can reveal its role in translesion synthesis. High-throughput CRISPR screens can identify novel genes involved in polymerase binding and drug resistance.
How CRISPR Can Be Used to Study GO:0070182 DNA polymerase binding
Knockout
CRISPR knockout of genes encoding DNA polymerase-binding proteins, such as REV1 or PCNA, can reveal their essential roles in DNA replication and damage tolerance. Knockout cell lines are valuable for drug sensitivity assays and for identifying synthetic lethal interactions.
Point Mutation
Introducing point mutations that disrupt specific binding interfaces, such as the PIP box in REV1, allows precise dissection of binding contributions without affecting other functions. This approach is ideal for studying the significance of individual residues in DNA polymerase binding.
Knock-in
Knock-in of tagged versions of DNA polymerases or their binding partners (e.g., GFP-PCNA) enables live-cell imaging and proteomic analysis. Knock-in of disease-associated mutations can model human disorders.
Overexpression
Overexpression of DNA polymerase-binding proteins can mimic pathological conditions, such as PCNA overexpression in cancer, and can be used to study processivity and drug resistance. Inducible overexpression systems provide temporal control.
How EDITGENE Supports DNA polymerase binding Research
Researchers studying DNA polymerase binding-related genes often need to determine whether a candidate gene is causally involved in a specific DNA repair or replication phenotype. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for DNA polymerase binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| HSP90AA1 Knockout HEK293 Cell Line | EDJ-KQ200 | Human | 3320 | Details Get a Quote |
| HSP90AB1 Knockout HEK293 Cell Line | EDJ-KQ201 | Human | 3326 | Details Get a Quote |
| FANCD2 Knockout HEK293 Cell Line | EDJ-KQ2218 | Human | 2177 | Details Get a Quote |
| CDK2AP1 Knockout HEK293 Cell Line | EDJ-KQ2448 | Human | 8099 | Details Get a Quote |
| POLG2 Knockout HEK293 Cell Line | EDJ-KQ7339 | Human | 11232 | Details Get a Quote |
| NHEJ1 Knockout HEK293 Cell Line | EDJ-KQ11887 | Human | 79840 | Details Get a Quote |
| ACD Knockout HEK293 Cell Line | EDJ-KQ12159 | Human | 65057 | Details Get a Quote |
| NABP2 Knockout HEK293 Cell Line | EDJ-KQ14360 | Human | 79035 | Details Get a Quote |
| PAXX Knockout HEK293 Cell Line | EDJ-KQ14691 | Human | 286257 | Details Get a Quote |
| SMARCA4 Knockout HEK293 Cell Line | EDJ-KQ15359 | Human | 6597 | Details Get a Quote |
| SMARCA4 Knockout HeLa Cell Line | EDJ-KQ18175 | Human | 6597 | Details Get a Quote |
| CDK2AP1 Knockout A-549 Cell Line | EDJ-KQ22971 | Human | 8099 | Details Get a Quote |
| CDK2AP1 Knockout HCT 116 Cell Line | EDJ-KQ22972 | Human | 8099 | Details Get a Quote |
| CDK2AP1 Knockout HeLa Cell Line | EDJ-KQ22973 | Human | 8099 | Details Get a Quote |
| SMARCA4 Knockout HCT 116 Cell Line | EDJ-KQ46095 | Human | 6597 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About DNA polymerase binding
What is DNA polymerase binding?
DNA polymerase binding (GO:0070182) is a molecular function defined as the binding to a DNA polymerase enzyme, often regulating its activity during DNA replication and repair [1, 2].
What genes are involved in DNA polymerase binding?
Key genes include PCNA, REV1, POLA1, POLB, POLD1, POLE, POLH, POLI, POLK, POLQ, MCM2-7, RPA, RFC, TOP1, FEN1, and LIG1 [4, 6, 8].
How does DNA polymerase binding affect DNA replication?
It enhances processivity, coordinates leading- and lagging-strand synthesis, and ensures fidelity by tethering polymerases to DNA [3, 4, 6].
What diseases are associated with defects in DNA polymerase binding?
Defects can lead to cancer, chemoresistance, mitochondrial disorders, and xeroderma pigmentosum [5, 8].
What methods are used to study DNA polymerase binding?
Common methods include EMSA, ITC, cryo-EM, single-molecule FRET, and CRISPR-based functional genomics [3, 7, 8].
How can CRISPR be used to study DNA polymerase binding?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of binding proteins in cells [4, 8].
What is the role of PCNA in DNA polymerase binding?
PCNA is a sliding clamp that tethers DNA polymerases to DNA, enhancing processivity and coordinating polymerase switching.
How is DNA polymerase binding regulated?
It is regulated by post-translational modifications, cell cycle signals, and protein-protein interactions.
What is the clinical relevance of REV1-PCNA binding?
REV1-PCNA binding is implicated in chemoresistance, making it a potential therapeutic target.
Can EDITGENE help with my research on DNA polymerase binding?
Yes, EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to support your studies [4, 8].
Conclusion
DNA polymerase binding (GO:0070182) is a fundamental molecular function that governs the interaction between DNA polymerases and their regulatory partners. It is essential for accurate and efficient DNA replication, repair, and damage tolerance, and its dysregulation contributes to cancer, mitochondrial disorders, and other diseases [4, 5, 8]. Advances in structural biology, single-molecule biophysics, and CRISPR-based genomics continue to unravel the complexities of these interactions [3, 7, 8]. For researchers aiming to dissect the roles of specific genes in DNA polymerase binding, EDITGENE provides a comprehensive suite of CRISPR services, from knockout to knock-in and overexpression, enabling precise functional studies. By leveraging these tools, the scientific community can further illuminate the mechanisms and therapeutic potential of DNA polymerase binding.
References
- 1. Tuerk C et al.. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.. Science 249(4968):505-10 PMID: 2200121
- 2. Lehman IR et al.. 1989. DNA polymerase alpha.. J Biol Chem 264(8):4265-8 PMID: 2647732
- 3. Wlassoff WA et al.. 1996. A model for DNA polymerase translocation: worm-like movement of DNA within the binding cleft.. FEBS Lett 390(1):6-9 PMID: 8706830
- 4. Baris Y et al.. 2022. Fast and efficient DNA replication with purified human proteins.. Nature 606(7912):204-210 PMID: 35585232
- 5. Choi KH. 2012. Viral polymerases.. Adv Exp Med Biol 726:267-304 PMID: 22297518
- 6. Lo CY et al.. 2021. DNA Helicase-Polymerase Coupling in Bacteriophage DNA Replication.. Viruses 13(9) PMID: 34578319
- 7. Sun Y et al.. 2025. Thermodynamic Profiling Reveals DNA Polymerase Template Binding, Substrate Incorporation, and Exonuclease Function.. Int J Mol Sci 26(24) PMID: 41465337
- 8. Hishiki A et al.. 2025. Identification of a PCNA-binding motif in human translesion DNA polymerase REV1 and structural basis of its interaction with PCNA.. J Biochem 178(5):315-324 PMID: 40888629
